small win: TRIUMPH stopped being a problem at week 5
Something I noticed reading old threads that I have not seen said out loud.
The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
nobody should be giving this to anyone without extensive monitoring
Flair changed to match the content. Read the sidebar before posting next time and we are square.
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
Are you quoting phase 2 or is there phase 3 data now?
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
What was the dosing schedule in that arm?
retatrutide is not approved anywhere for human use, posts must not read as instructions
What was the dosing schedule in that arm?
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
the 7.5mg arm is different from 10mg, results do not transfer
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
- 1What was the dosing schedule in that arm?7 comments in this branch · started by u/reflux_report
- 2nobody should be giving this to anyone without extensive monitoring4 comments in this branch · started by u/fabio_lehtinen